Investor Prince Khalid Bin Alwaleed is set to join the board of Vesalius Longevity Labs, which is researching the potential for using peptides to increase human’s healthy lifespan.
Subscriber only content
An active subscription is required to view this article
Subscribe to Gulf States Newsletter